Compare DexCom, Inc. (DXCM) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Five9 Inc — how do they compare? DexCom, Inc. trades at $91.34 (market cap $34.26B), while Five9 Inc trades at $33.69 (market cap $2.33B). The key difference: DexCom, Inc. is far larger — about 14.7× Five9 Inc's market cap. Which is the better fit depends on your goals.
| DXCM | FIVN | |
|---|---|---|
Market Cap | $34.26B | $2.33B |
Sector | Health | Technology |
52-Week High | $90.80 | $34.48 |
52-Week Low | $54.84 | $13.61 |
Enterprise Value | $33.72B | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
